clinical trial · NCT05610319
Treat & Extend Versus Fixed Dosing With Faricimab for Management of Diabetic Macular Edema: A Pragmatic, Multi-center, Open-label, Randomized, Controlled Trial
McMaster University·phase4·active not recruiting·n = 446
Diabetic Macular EdemaFaricimab
brief summary
This study will assess a pragmatic, treat and extend regimen of faricimab against the standard of a fixed dosing regimen.
started
May 1, 2023
primary completion
Dec 1, 2026
completion
Dec 1, 2026
last updated
Apr 17, 2026
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol